ACIP provides recommendations for the use of inactivated JE vaccine in travelers and military personnel.
Japanese encephalitis (JE) vaccine was available in the United States from 1983 through 1987 on an investigational basis, through travel clinics in collaboration with CDC (1). JE vaccine manufactured by Biken and distributed by Connaught Laboratories, Inc. (Japanese encephalitis virus vaccine, inactivated, JE-VAX), was licensed on December 10, 1992, to meet the needs of increasing numbers of U.S. residents traveling to Asia and to accommodate the needs of the U.S. military.
No takes yet. Share an insight, caveat, or question.
A 1993 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: